Alvara Therapeutics ApS

CVR 46632516 · Private limited company (ApS) · Active · Medium risk

Alvara Therapeutics ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. CEO: Anders Bach, Marie Elodie Hélène Cadot.

Bankruptcy risk for Alvara Therapeutics ApS

2.0%
probability of bankruptcy within 12 months
Medium risk

1.4 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports0 · bankruptcy rate 16.7%1.9×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Number of CEOs2 · bankruptcy rate 5.7%0.65×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×
Registered owners2 · bankruptcy rate 7.6%0.87×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46632516
Status
Active
Company type
Private limited company (ApS)
Founded
(0 years)
Address
c/o BII, Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 20k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEOAnders BachCurrent
CEOMarie Elodie Hélène CadotCurrent
Owner (50%)Anders Bach ApSCurrent
Owner (50%)LN Stjerne ApSCurrent
FounderAnders Bach ApSCurrent
FounderLN Stjerne ApSCurrent

The CEOs' other companies

Anders Bach – 2 other companies

Marie Elodie Hélène Cadot – 1 other companies

Address history (0 moves)

c/o BII, Ole Maaløes Vej 3, 2200 København N

Other companies at the same address

Similar companies in København

Questions and answers about Alvara Therapeutics ApS

Has Alvara Therapeutics ApS gone bankrupt?

No, Alvara Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Alvara Therapeutics ApS?

Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.

Who is the CEO of Alvara Therapeutics ApS?

Anders Bach, Marie Elodie Hélène Cadot are the CEOs of Alvara Therapeutics ApS.

When was Alvara Therapeutics ApS founded?

Alvara Therapeutics ApS was founded on 10 July 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.